Bridgefront Capital’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,084
Closed -$178K 662
2025
Q1
$178K Buy
+13,084
New +$178K 0.05% 540